Alex Carchidi from Motley Fool - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Alex Carchidi Motley Fool Writer, consultant, entrepreneur. Motley Fool. Boston, Massachusetts writingconsultingentrepreneurshipfinance		Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers - 15 days ago Does This New Development Make CVS Stock a Buy or a Sell? - about 1 month ago 3 Things You Need to Know if You Buy Iovance Biotherapeutics Today - 2 months ago 1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More - 2 months ago Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More - 2 months ago This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money - 3 months ago Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock? - 3 months ago Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move - 3 months ago If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy - 5 months ago The Best Biotech Stock to Invest $1,000 in Right Now - 5 months ago 3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation - 5 months ago Is AbbVie a Millionaire Maker? - 7 months ago The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation - 7 months ago Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy? - 8 months ago Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling? - 8 months ago 3 Biopharma Stocks You Don't Want to Miss in the New Bull Market - 9 months ago Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now. - 9 months ago Nano-X Imaging Could Be Teaming Up With Nvidia, and Its Stock Is Flying. Can It Continue? - 9 months ago Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen? - 9 months ago Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock? - 9 months ago Could Green Thumb Industries Stock Help You Become a Millionaire? - 9 months ago 3 Pricey Stocks I'll Be Watching Like a Hawk in 2024 - 10 months ago Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 - 10 months ago 3 Simple Tricks That Every Investor Should Use (but Most Don't) - 10 months ago Better Growth Investment: Ginkgo Bioworks vs. Shiba Inu - 10 months ago Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy? - 11 months ago 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow - 11 months ago Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now - 11 months ago Nvidia Is Investing in Biotech Like Wild. Here's What It Means for the Stock. - 11 months ago Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock? - 11 months ago AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors - 11 months ago This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks - 11 months ago AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024? - 11 months ago Everyone Is Talking About Tilray Brands Stock. Is It a Good Long-Term Option? - 12 months ago Is Aurora Cannabis Stock a Buy Now? - 12 months ago This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks - 12 months ago 2 High-Yield Dividend Stocks That'll Probably Let You Down - 12 months ago Where Will Medical Properties Trust Be in 5 Years? - 12 months ago With More States Voting to Legalize Marijuana, Is Canopy Growth Stock a Buy? - 12 months ago Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters. - 12 months ago Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying? - 12 months ago Could Ozempic Harm These 3 Medical Device Stocks? - 12 months ago Looking for a High-Yield Dividend Stock? Avoid Buying Walgreens Boots Alliance. - 12 months ago Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off? - 12 months ago Is Beam Therapeutics Stock a Buy Now? - 12 months ago Is DexCom the Next Big Growth Stock? - about 1 year ago AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock - about 1 year ago 3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report - about 1 year ago Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win? - about 1 year ago Could Bristol-Myers Squibb Stock Help You Retire A Millionaire? - about 1 year ago